A new prospective trial finds AI assistance significantly increases detection of suspicious lung nodules in low-dose chest CT screenings.
Key Details
- 1Published in American Journal of Roentgenology; study compares radiologist performance with and without AI support.
- 2First prospective real-world evidence addressing limitations of prior retrospective research on AI in lung cancer screening.
- 3Study involved consecutive asymptomatic patients undergoing low-dose chest CT from May to September 2025.
- 4Patients were randomized to AI-assisted interpretation or radiologist-only reading arms.
- 5Primary outcomes measured: interpretation times and nodule detection rates, with secondary analysis on follow-up recommendations.
Why It Matters
Prospective, real-world data are essential for validating AI performance beyond retrospective analyses. The results support integrating AI into routine lung cancer screening, potentially improving early lung cancer detection and workflow efficiency.
Source
Radiology Business
Related News
•AuntMinnie
Radiologists Struggle to Spot AI-Generated Radiology Images
Radiologists correctly identify AI-generated images 75% of the time, with CT and MRI images being particularly challenging to spot.
•Radiology Business
Framework Assesses Real-World Financial Impact of Radiology AI Adoption
A new analysis presents a financial calculator for objectively assessing the return on investment (ROI) of implementing radiology AI solutions.
•Radiology Business
Study Finds Disparities in Access to Stroke Imaging AI Tools
Research shows access to AI stroke detection tools is concentrated in resource-rich hospitals despite Medicare incentives.